Hemoglobin A, Glycosylated - Metabolism
Research News and Information

Saturday, November 21, 2009

Prediction of proliferative diabetic retinopathy with hemoglobin level.

30 Oct 2009 OBJECTIVE: To investigate the role of hemoglobin (HGB) level in predicting proliferative diabetic retinopathy (PDR). METHODS: We assessed 426 individuals without PDR at baseline (213 men; 213 women) from the Pittsburgh Epidemiology of Diabetes ... Read more...

A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).

30 Oct 2009 PURPOSE: To study glycemic control and hypoglycemia development upon initiation of insulin through a self-titration schedule in a 24-week trial, conducted with 4875 insulin-naïve patients with poorly controlled type 2 diabetes, predominantly in a ... Read more...

The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial.

24 Oct 2009 BACKGROUND: Although African American adults bear a disproportionate burden from diabetes mellitus (DM), few randomized controlled trials have tested culturally appropriate interventions to improve DM care. METHODS: We randomly assigned 542 African ... Read more...

Latest indexed articles for 'Hemoglobin A, Glycosylated - Metabolism'

These are the very latest articles for this heading:

• Prediction of proliferative diabetic retinopathy with hemoglobin level. 30 Oct 2009
• A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). 30 Oct 2009
• The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. 24 Oct 2009
• Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. 11 Oct 2009
• Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. 19 Sep 2009
• Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. 17 Sep 2009
• Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. 14 Sep 2009
• Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. 9 Sep 2009
• Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes. 30 Aug 2009
• Structured patient education: the X-PERT Programme. 30 Aug 2009
• Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. 30 Aug 2009
• Efficacy and safety of incretin based therapies: clinical trial data. 30 Aug 2009
• Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. 30 Aug 2009
• Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: a cohort study. 30 Aug 2009
• Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 30 Aug 2009
• Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke. 30 Aug 2009
• [Improvement in glycemic control, cardiovascular risk factors and anthropometric data in type 2 diabetic patients after the switch from biphasic human insulin to biphasic premix analog insulin aspart] 28 Aug 2009
• Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats. 16 Aug 2009
• Intensive glucose control and cardiovascular outcomes. 13 Aug 2009
• The German ACROSTUDY: past and present. 12 Aug 2009

See a longer list of these articles.

Technical information about 'Hemoglobin A, Glycosylated'

Definition: Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.

Registry Number: 0

Descriptor UI: D006442

Alternative terms: Hemoglobin A, Glycosylated; Hb A1a+b; Hb A1c; HbA1; Glycosylated Hemoglobin A; Hb A1; Glycohemoglobin A; Hemoglobin A(1); Hemoglobin, Glycosylated A1b; A1b Hemoglobin, Glycosylated; Glycosylated A1b Hemoglobin; Hb A1b; Hemoglobin, Glycosylated A1a-1; A1a-1 Hemoglobin, Glycosylated; Glycosylated A1a-1 Hemoglobin; Hemoglobin, Glycosylated A1a 1; Hb A1a-1; Hb A1a-2; Hemoglobin, Glycosylated; Glycosylated Hemoglobin; Glycated Hemoglobins; Hemoglobins, Glycated;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D09.408.375; D12.776.124.400.405.440; D12.776.422.316.762.380.440;

History Note: 82

Technical Notes: urine: coord IM with HEMOGLOBINURIA (IM); DF: note short X refs